Back to the Top
The following message was posted to: PharmPK
Why usually 1. sponsors for BE study ( drugs with
long half life) do not prefer for parallel design,
they prefer cross over design.
2. sponsors do not prefer trunacted study
for long half life drugs.
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Study design - Drugs with Long half life" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (firstname.lastname@example.org)